Abstract
Genetic testing to identify genetic syndromes and copy number variants (CNVs) via whole genome platforms such as chromosome microarray (CMA) or exome sequencing (ES) is routinely performed clinically, and is considered by a variety of organizations and societies to be a “first-tier” test for individuals with developmental delay (DD), intellectual disability (ID), or autism spectrum disorder (ASD). However, in the context of schizophrenia, though CNVs can have a large effect on risk, genetic testing is not typically a part of routine clinical care, and no clinical practice guidelines recommend testing. This raises the question of whether CNV testing should be similarly performed for individuals with schizophrenia. Here we consider this proposition in light of the history of genetic testing for ID/DD and ASD, and through the application of an ethical analysis designed to enable robust, accountable and justifiable decision-making. Using a systematic framework and application of relevant bioethical principles (beneficence, non-maleficence, autonomy, and justice), our examination highlights that while CNV testing for the indication of ID has considerable benefits, there is currently insufficient evidence to suggest that overall, the potential harms are outweighed by the potential benefits of CNV testing for the sole indications of schizophrenia or ASD. However, although the application of CNV tests for children with ASD or schizophrenia without ID/DD is, strictly speaking, off-label use, there may be clinical utility and benefits substantive enough to outweigh the harms. Research is needed to clarify the harms and benefits of testing in pediatric and adult contexts. Given that genetic counseling has demonstrated benefits for schizophrenia, and has the potential to mitigate many of the potential harms from genetic testing, any decisions to implement genetic testing for schizophrenia should involve high-quality evidence-based genetic counseling.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdul-Rahman OA, Hudgins L (2006) The diagnostic utility of a genetics evaluation in children with pervasive developmental disorders. Genet Med off J Am Coll Med Genet 8(1):50–54
Ackerman MJ (2015) Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue. Heart Rhythm 12(11):2325–2331. https://doi.org/10.1016/j.hrthm.2015.07.002
Ahn K, Gotay N, Andersen TM, Anvari AA, Gochman P, Lee Y, Rapoport JL (2014) High rate of disease-related copy number variations in childhood onset schizophrenia. Mol Psychiatry 19(5):568–572. https://doi.org/10.1038/mp.2013.59
Almqvist EW, Brinkman RR, Wiggins S, Hayden MR, The Canadian Collaborative Study of, Predictive Testing (2003) Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for huntington’s disease. Clin Genet 64(4):300–309. https://doi.org/10.1034/j.1399-0004.2003.00157.x
Andermann A, Blancquaert I, Beauchamp S, Déry V (2008) Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 86(4):317–319. https://doi.org/10.2471/blt.07.050112
Andermann A, Blancquaert I, Beauchamp S, Costea I (2011) Guiding policy decisions for genetic screening: developing a systematic and transparent approach. Public Health Genom 14(1):9–16. https://doi.org/10.1159/000272898
Armando M, Ciampoli M, Padula MC, Amminger P, De Crescenzo F, Maeder J, Papaleo F (2020) Favorable effects of omega-3 polyunsaturated fatty acids in attentional control and conversion rate to psychosis in 22q112 deletion syndrome. Neuropharmacology 168:107995
Austin JC (2019) Evidence-based genetic counseling for psychiatric disorders: a road map. Cold Spring Harb Perspect Med 10:a036608
Baker K, Raymond FL, Bass N (2012) Genetic investigation for adults with intellectual disability: opportunities and challenges. Curr Opin Neurol 25(2):150–158. https://doi.org/10.1097/WCO.0b013e328351820e
Baker K, Costain G, Fung WL, Bassett AS (2014) Chromosomal microarray analysis-a routine clinical genetic test for patients with schizophrenia. Lancet Psychiatry 1(5):329–331. https://doi.org/10.1016/S2215-0366(14)70308-6
Balakrishna T, Curtis D (2019) Assessment of potential clinical role for exome sequencing in schizophrenia. Schizophr Bull 46(2):328–335
Baldwin EL, Lee J, Blake DM, Bunke BP, Alexander CR, Kogan AL, Martin CL (2008) Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med 10:415. https://doi.org/10.1097/GIM.0b013e318177015c
Barton KS, Tabor HK, Starks H, Garrison NA, Laurino M, Burke W (2018) Pathways from autism spectrum disorder diagnosis to genetic testing. Genet Med off J Am Coll Med Genet 20(7):737–744. https://doi.org/10.1038/gim.2017.166
Bassett AS, Chow EWC (2008) Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 10(2):148–157. https://doi.org/10.1007/s11920-008-0026-1
Borg I, Delhanty JD, Baraitser M (1995) Detection of hemizygosity at the elastin locus by FISH analysis as a diagnostic test in both classical and atypical cases of williams syndrome. J Med Genet 32(9):692–696. https://doi.org/10.1136/jmg.32.9.692
Borle K, Morris E, Inglis A, Austin J (2018) Risk communication in genetic counseling: exploring uptake and perception of recurrence numbers, and their impact on patient outcomes. Clin Genet 94(2):239–245. https://doi.org/10.1111/cge.13379
Bray NJ, O’Donovan MC (2019) The genetics of neuropsychiatric disorders. Brain Neurosci Adv. https://doi.org/10.1177/2398212818799271
Bryson SE, Clark BS, Smith IM (1988) First report of a canadian epidemiological study of autistic syndromes. J Child Psychol Psychiatry 29(4):433–445. https://doi.org/10.1111/j.1469-7610.1988.tb00735.x
Butler MG (2019) Magnesium supplement and the 15q11.2 BP1-BP2 microdeletion (burnside-butler) syndrome: a potential treatment? Int J Mol Sci 20(12):2914. https://doi.org/10.3390/ijms20122914
Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM (2003) Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 178(2):77–81
Chang H, Li L, Peng T, Li M, Gao L, Xiao X (2016) Replication analyses of four chromosomal deletions with schizophrenia via independent large-scale meta-analyses. Am J Med Genet B Neuropsychiatr Genet 171(8):1161–1169. https://doi.org/10.1002/ajmg.b.32502
Chodirker BN, Chudley AE (2008) Routine genetic testing for asperger syndrome. Genet Med 10:843. https://doi.org/10.1097/GIM.0b013e31818b0c76
Committee on Genetics (2001) American academy of pediatrics: health care supervision for children with williams syndrome. Pediatrics 107(5):1192–1204
Costain G, Chow EW, Ray PN, Bassett AS (2012) Caregiver and adult patient perspectives on the importance of a diagnosis of 22q112 deletion syndrome. J Intell Disabil Res JIDR 56(6):641–651. https://doi.org/10.1111/j.1365-2788.2011.01510.x
Costain G, Lionel AC, Merico D, Forsythe P, Russell K, Lowther C, Bassett AS (2013) Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays. Hum Mol Genet 22(22):4485–4501. https://doi.org/10.1093/hmg/ddt297
Costain G, Esplen MJ, Toner B, Scherer SW, Meschino WS, Hodgkinson KA, Bassett AS (2014) Evaluating genetic counseling for individuals with schizophrenia in the molecular age. Schizophr Bull 40(1):78–87. https://doi.org/10.1093/schbul/sbs138
de Giambattista C, Ventura P, Trerotoli P, Margari M, Palumbi R, Margari L (2019) Subtyping the autism spectrum disorder: Comparison of children with high functioning autism and asperger syndrome. J Autism Dev Disord 49(1):138–150. https://doi.org/10.1007/s10803-018-3689-4
Dean K, Murray RM (2005) Environmental risk factors for psychosis. Dialog Clin Neurosci 7(1):69–80. https://pubmed.ncbi.nlm.nih.gov/16060597. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181718/
Dori N, Green T, Weizman A, Gothelf D (2017) The effectiveness and safety of antipsychotic and antidepressant medications in individuals with 22q112 deletion syndrome. J Child Adolesc Psychopharmacol 27(1):83–90. https://doi.org/10.1089/cap.2014.0075
Epstein LI (1982) Clinical ethics: a practical approach to ethical decisions in clinical medicine. J Leg Med 3(3):490–495. https://doi.org/10.1080/01947648209513363
Esplen MJ, Cappelli M, Wong J, Bottorff JL, Hunter J, Carroll J, Meschino W (2013) Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2012-002227
Evaluation of automatic class III designation (de novo) summaries (2019) US official news
Finucane B, Haines Dirrigl K, Simon EW (2001) Characterization of self-injurious behaviors in children and adults with smith-magenis syndrome. Am J Ment Retard 106(1):52–58. https://doi.org/10.1352/0895-8017(2001)1062.0.CO;2
Finucane BM, Myers SM, Martin CL, Ledbetter DH (2020) Long overdue: Including adults with brain disorders in precision health initiatives. Curr Opin Genet Dev 65:47–52. https://doi.org/10.1016/j.gde.2020.05.001
Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE (1995) The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 9(2):132–140. https://doi.org/10.1038/ng0295-132
Fung WL, Butcher NJ, Costain G, Andrade DM, Boot E, Chow EW, Bassett AS (2015) Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med off J Am Coll Med Genet 17(8):599–609. https://doi.org/10.1038/gim.2014.175
Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, Buxbaum JD (2014) Most genetic risk for autism resides with common variation. Nature Genet 46:881. https://doi.org/10.1038/ng.3039
Gersh M, Grady D, Rojas K, Lovett M, Moyzis R, Overhauser J (1997) Development of diagnostic tools for the analysis of 5p deletions using interphase FISH. Cytogenet Cell Genet 77(3–4):246–251. https://doi.org/10.1159/000134586
Gershon ES, Alliey-Rodriguez N (2013) New ethical issues for genetic counseling in common mental disorders. Am J Psychiatry 170(9):968–976. https://doi.org/10.1176/appi.ajp.2013.12121558
Godfrey E, Clark P (2014) Developing standards for chromosomal microarray testing counselling in paediatrics. Acta Paediatr 103(6):574–577. https://doi.org/10.1111/apa.12601
Gothelf D, Frisch A, Munitz H, Rockah R, Laufer N, Mozes T, Frydman M (1999) Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 35(2):105–112
Griesi-Oliveira K, Sertié AL (2017) Autism spectrum disorders: an updated guide for genetic counseling. Einstein (sao Paulo Braz) 15(2):233–238. https://doi.org/10.1590/S1679-45082017RB4020
Grozeva D, Conrad DF, Barnes CP, Hurles M, Owen MJ, O’Donovan MC, WTCCC (2012) Independent estimation of the frequency of rare CNVs in the UK population confirms their role in schizophrenia. Schizophr Res 135(1–3):1–7. https://doi.org/10.1016/j.schres.2011.11.004
Grugni G, Sartorio A, Crinò A (2016) Growth hormone therapy for Prader-Willi syndrome: challenges and solutions. Ther Clin Risk Manag 12:873–881. https://doi.org/10.2147/TCRM.S70068
Hafner H, Maurer K, Loffler W, Fatkenheuer B, an der Heiden W, Riecher-Rossler A, Gattaz WF (1994) The epidemiology of early schizophrenia. influence of age and gender on onset and early course. Br J Psychiatry Suppl 23:29–38
Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psycho off J Div Health Psychol Am Psychol Assoc 28(4):510–518. https://doi.org/10.1037/a0014778
Hayeems RZ, Babul-Hirji R, Hoang N, Weksberg R, Shuman C (2016) Parents’ experience with pediatric microarray: transferrable lessons in the era of genomic counseling. J Genet Couns 25(2):298–304. https://doi.org/10.1007/s10897-015-9871-3
Herman GE, Henninger N, Ratliff-Schaub K, Pastore M, Fitzgerald S, McBride KL (2007) Genetic testing in autism: how much is enough? Genet Med 9:268. https://doi.org/10.1097/GIM.0b013e31804d683b
Hippman C, Ringrose A, Inglis A, Cheek J, Albert AY, Remick R, Austin JC (2016) A pilot randomized clinical trial evaluating the impact of genetic counseling for serious mental illnesses. J Clin Psychiatry 77(2):190. https://doi.org/10.4088/JCP.14m09710
Ho KS, Wassman ER, Baxter AL, Hensel CH, Martin MM, Prasad A, Butler MG (2016) Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders using an ultra-high resolution chromosomal microarray optimized for neurodevelopmental disorders. Int J Mol Sci 17(12):2070. https://doi.org/10.3390/ijms17122070
Hoffman-Andrews L (2018) The known unknown: the challenges of genetic variants of uncertain significance in clinical practice. J Law Biosci 4(3):648–657. https://doi.org/10.1093/jlb/lsx038
Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke D (2003) Behavioural phenotypes associated with specific genetic disorders: Evidence from a population-based study of people with Prader-Willi syndrome. Psychol Med 33(1):141–153. https://doi.org/10.1017/s0033291702006736
Hostiuc S, Rusu MC, Negoi I, Drima E (2018) Testing decision-making competency of schizophrenia participants in clinical trials. A meta-analysis and meta-regression. BMC Psychiatry 18(1):2. https://doi.org/10.1186/s12888-017-1580-z
Inglis A, Koehn D, McGillivray B, Stewart SE, Austin J (2015) Evaluating a unique, specialist psychiatric genetic counseling clinic: uptake and impact. Clin Genet 87(3):218–224. https://doi.org/10.1111/cge.12415
Jacquemont ML, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, Lyonnet S, Philippe A (2006) Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 43(11):843–849
Jonsen AR, Siegler M, Winslade WJ (2002) Clinical ethics: A Practical Approach to Ethical Decisions in Clinical Medicine, 5 edn. Medical Publishing Division, McGraw Hill, New York. http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009878944&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
Karimi P, Kamali E, Mousavi SM, Karahmadi M (2017) Environmental factors influencing the risk of autism. J Res Med Sci 22:27. https://doi.org/10.4103/1735-1995.200272
Kaufmann WE, Kidd SA, Andrews HF, Budimirovic DB, Esler A, Haas-Givler B, Berry-Kravis E (2017) Autism spectrum disorder in fragile X syndrome: Cooccurring conditions and current treatment. Pediatrics 139(Supplement 3):S194–S206. https://doi.org/10.1542/peds.2016-1159F
Kearney HM, South ST, Wolff DJ, Lamb A, Hamosh A, Rao KW (2011) American college of medical genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med off J Am Coll Med Genet 13(7):676–679
Kelly N, Makarem DC, Wasserstein MP (2016) Screening of newborns for disorders with high benefit-risk ratios should be mandatory. J Law Med Ethics 44(2):231–240. https://doi.org/10.1177/1073110516654133
Keser I, Luleci G, Keskin V (1998) Cytogenetic studies among mentally retarded children attending to special classes of MEBARAM in antalya province. Marmara Med J 11:201–203
Kinsinger FS (2009) Beneficence and the professional’s moral imperative. J Chiropr Hum 16(1):44–46. https://doi.org/10.1016/j.echu.2010.02.006
Klein-Tasman B, Phillips KD, Lord C, Mervis CB, Gallo FJ (2009) Overlap with the autism spectrum in young children with Williams syndrome. J Dev Behav Pediatr JDBP 30(4):289–299. https://doi.org/10.1097/DBP.0b013e3181ad1f9a
Knight SJ, Flint J (2000) Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet 37(6):401–409. https://doi.org/10.1136/jmg.37.6.401
Knight SJ, Horsley SW, Regan R, Lawrie NM, Maher EJ, Cardy DL, Kearney L (1997) Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet EJHG 5(1):1–8
Kraus C, Vanicek T, Weidenauer A, Khanaqa T, Stamenkovic M, Lanzenberger R, Kasper S (2018) DiGeorge syndrome: relevance of psychiatric symptoms in undiagnosed adult patients. Wien Klin Wochenschr 130(7–8):283–287. https://doi.org/10.1007/s00508-018-1335-y
Kronfeldner ME (2009) Genetic determinism and the innate-acquired distinction in medicine. Med Stud 1(2):167–181. https://doi.org/10.1007/s12376-009-0014-8
Kushima I, Aleksic B, Nakatochi M, Shimamura T, Okada T, Uno Y, Ozaki N (2018) Comparative analyses of copy-number variation in autism spectrum disorder and schizophrenia reveal etiological overlap and biological insights. Cell Rep. https://doi.org/10.1016/j.celrep.2018.08.022
Lai MC, Lombardo MV, Baron-Cohen S (2014) Autism. Lancet 383:896–910
Laje G, Morse R, Richter W, Ball J, Pao M, Smith ACM (2010) Autism spectrum features in Smith-Magenis syndrome. Am J Med Genet Part C Sem Med Genet 154C(4):456–462. https://doi.org/10.1002/ajmg.c.30275
Lambert TJR, Newcomer JW (2009) Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Med J Aust 190(4):S39-42
Lauritsen M, Mors O, Mortensen PB, Ewald H (1999) Infantile autism and associated autosomal chromosome abnormalities: a register-based study and a literature survey. J Child Psychol Psychiatry 40(3):335–345. https://doi.org/10.1111/1469-7610.00451
Lemay JF, Herbert AR, Dewey DM, Innes AM (2003) A rational approach to the child with mental retardation for the paediatrician. Paediatr Child Health 8(6):345–356. https://doi.org/10.1093/pch/8.6.345
Lowther C, Merico D, Costain G, Waserman J, Boyd K, Noor A, Bassett AS (2017) Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia. Genome Med 9(1):105-z. https://doi.org/10.1186/s13073-017-0488-z
Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, Ward PA (2007) Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS ONE 2(3):e327. https://doi.org/10.1371/journal.pone.0000327
Makhnoon S, Garrett LT, Burke W, Bowen DJ, Shirts BH (2019) Experiences of patients seeking to participate in variant of uncertain significance reclassification research. J Commun Genet 10(2):189–196. https://doi.org/10.1007/s12687-018-0375-3
Manikam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisma FM, ACMG Board of Directors (2021) Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence based clinical guideline of the American College of Medical Genetics and Genomics. Genet Med
Manning M, Hudgins L, Practice P, Committee G (2010) Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med off J Am Coll Med Genet 12(11):742–745. https://doi.org/10.1097/GIM.0b013e3181f8baad
Martin CL, Wain KE, Oetjens MT, Tolwinski K, Palen E, Hare-Harris A, Ledbetter DH (2020) Identification of neuropsychiatric copy number variants in a health care system population. JAMA Psychiat. https://doi.org/10.1001/jamapsychiatry.2020.2159
McMahon WM, Baty BJ, Botkin J (2006) Genetic counseling and ethical issues for autism. Am J Med Genet Part C Sem Med Genet 142C(1):52–57. https://doi.org/10.1002/ajmg.c.30082
Meiser B, Dunn S (2000) Psychological impact of genetic testing for Huntington’s disease: an update of the literature. J Neurol Neurosurg Psychiatry 69(5):574–578. https://doi.org/10.1136/jnnp.69.5.574
Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, Ross T (2018) Prevalence of variant reclassification following hereditary cancer genetic testing. JAMA 320(12):1266–1274. https://doi.org/10.1001/jama.2018.13152
Miller R, Mason SE (2005) Shame and guilt in first-episode schizophrenia and schizoaffective disorders. J Contemp Psychother 35(2):211–221. https://doi.org/10.1007/s10879-005-2701-4
Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Ledbetter DH (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86(5):749–764. https://doi.org/10.1016/j.ajhg.2010.04.006
Moghe M, Patel ZM, Peter JJ, Ambani LM (1981) Cytogenetic studies in a selected group of mentally retarded children. Hum Genet 58(2):184–187. https://doi.org/10.1007/BF00278708
Moldovan R, Pintea S, Austin J (2017) The efficacy of genetic counseling for psychiatric disorders: a meta-analysis. J Genet Couns 26(6):1341–1347. https://doi.org/10.1007/s10897-017-0113-8
Moreno-De-Luca D, Ross ME, Ross DA (2018) Leveraging the power of genetics to bring precision medicine to psychiatry: too little of a good thing? Biol Psychiatr 83(8):e45–e46. https://doi.org/10.1016/j.biopsych.2018.02.013
Munnich A, Demily C, Frugere L, Duwime C, Malan V, Barcia G, Assouline M (2019) Impact of on-site clinical genetics consultations on diagnostic rate in children and young adults with autism spectrum disorder. Mol Autism 10:33–42. https://doi.org/10.1186/s13229-019-0284-2
Murakami Y, Okamura H, Sugano K, Yoshida T, Kazuma K, Akechi T, Uchitomi Y (2004) Psychologic distress after disclosure of genetic test results regarding hereditary nonpolyposis colorectal carcinoma. Cancer 101(2):395–403. https://doi.org/10.1002/cncr.20363
Nag HE, Hoxmark LB, Naerland T (2019) Parental experiences with behavioural problems in Smith-Magenis syndrome: the need for syndrome-specific competence. J Intell Disabil JOID 23(3):359–372. https://doi.org/10.1177/1744629519847375
National Society of Genetic Counselors’ Definition Task Force, Resta R, Biesecker BB, Bennett RL, Blum S, Hahn SE, Williams JL (2006) A new definition of genetic counseling: national society of genetic counselors’ task force report. J Genet Couns 15(2):77–83. https://doi.org/10.1007/s10897-005-9014-3
Ning Y, Roschke A, Smith ACM, Macha M, Precht K, Riethman H, Brown WRA (1996) A complete set of human telomeric probes and their clinical application. Nat Genet 14(1):86–89. https://doi.org/10.1038/ng0996-86
O’Neill SC, Rini C, Goldsmith RE, Valdimarsdottir H, Cohen LH, Schwartz MD (2009) Distress among women receiving uninformative BRCA1/2 results: 12-month outcomes. Psycho Oncol 18(10):1088–1096. https://doi.org/10.1002/pon.1467
Oliver C, Berg K, Moss J, Arron K, Burbidge C (2011) Delineation of behavioral phenotypes in genetic syndromes: characteristics of autism spectrum disorder, affect and hyperactivity. J Autism Dev Disord 41(8):1019–1032. https://doi.org/10.1007/s10803-010-1125-5
Ozonoff S, Heung K, Byrd R, Hansen R, Hertz-Picciotto I (2008) The onset of autism: patterns of symptom emergence in the first years of life. Autism Res off J Int Soc Autism Res 1(6):320–328. https://doi.org/10.1002/aur.53
Parisi L, Di Filippo T, Roccella M (2015) Behavioral phenotype and autism spectrum disorders in cornelia de lange syndrome. Ment Illn 7(2):5988. https://doi.org/10.4081/mi.2015.5988
Poisson A, Nicolas A, Cochat P, Sanlaville D, Rigard C, de Leersnyder H, Demily C (2015) Behavioral disturbance and treatment strategies in Smith-Magenis syndrome. Orphanet J Rare Dis 10:111. https://doi.org/10.1186/s13023-015-0330-x
Rapoport J, Chavez A, Greenstein D, Addington A, Gogtay N (2009) Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited. J Am Acad Child Adolesc Psychiatry 48(1):10–18. https://doi.org/10.1097/CHI.0b013e31818b1c63
Rees E, Walters JT, Georgieva L, Isles AR, Chambert KD, Richards AL, Kirov G (2014) Analysis of copy number variations at 15 schizophrenia-associated loci. Br J Psychiatry J Ment Sci 204(2):108–114. https://doi.org/10.1192/bjp.bp.113.131052
Rego S, Dagan-Rosenfeld O, Zhou W, Sailani MR, Limcaoco P, Colbert E, Snyder MP (2018) High-frequency actionable pathogenic exome variants in an average-risk cohort. Cold Spring Harbor Mol Case Stud 4(6):a003178. https://doi.org/10.1101/mcs.a003178
Reiff M, Giarelli E, Bernhardt BA, Easley E, Spinner NB, Sankar PL, Mulchandani S (2015) Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. J Autism Dev Disord 45(10):3262–3275. https://doi.org/10.1007/s10803-015-2489-3
Rødgaard E, Jensen K, Vergnes J, Soulières I, Mottron L (2019) Temporal changes in effect sizes of studies comparing individuals with and without autism: a meta-analysis. JAMA Psychiat 76(11):1124–1132. https://doi.org/10.1001/jamapsychiatry.2019.1956
Rosenfeld JA, Coppinger J, Bejjani BA, Girirajan S, Eichler EE, Shaffer LG, Ballif BC (2009) Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord 2(1):26–38. https://doi.org/10.1007/s11689-009-9037-4
Rumsey RK, Rudser K, Delaney K, Potegal M, Whitley CB, Shapiro E (2014) Acquired autistic behaviors in children with mucopolysaccharidosis type IIIA. J Pediatr 164(5):1147-1151.e1. https://doi.org/10.1016/j.jpeds.2014.01.007
Santos CB, Boy RT, Santos JM, Silva MPS, Pimentel MMG (2000) Chromosomal investigations in patients with mental retardation and/or congenital malformations. Genet Mol Biol 23:703–707
Schaefer GB, Lutz RE (2006) Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med 8(9):549–556. https://doi.org/10.1097/01.gim.0000237789.98842.f1
Schaefer GB, Mendelsohn NJ (2013) Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 15:399. https://doi.org/10.1038/gim.2013.32
Schaefer GB, Mendelsohn NJ, Practice P, Committee G (2008) Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med off J Am Coll Med Genet 10(4):301–305. https://doi.org/10.1097/GIM.0b013e31816b5cc9
Semaka A, Austin J (2019) Patient perspectives on the process and outcomes of psychiatric genetic counseling: an “Empowering encounter.” J Genet Couns. https://doi.org/10.1002/jgc4.1128
Shaffer LG, American College College of Medical Genetics Professional Practice and Guidelines Committee (2005) American college of medical genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation. Genet Med off J Am Coll Med Genet 7(9):650–654. https://doi.org/10.1097/01.gim.0000186545.83160.1e
Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, Autism Consortium Clinical Genetics/DNA, Diagnostics Collaboration (2010) Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125(4):e727–e735. https://doi.org/10.1542/peds.2009-1684
Silva M, de Leeuw N, Mann K, Schuring-Blom H, Morgan S, Giardino D, Hastings R (2019) European guidelines for constitutional cytogenomic analysis. Eur J Hum Genet 27(1):1–16. https://doi.org/10.1038/s41431-018-0244-x
Singh T, Walters JTR, Johnstone M, Curtis D, Suvisaari J, Torniainen M, Barrett JC (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49(8):1167–1173. https://doi.org/10.1038/ng.3903
Slavin TP, Manjarrez S, Pritchard CC, Gray S, Weitzel JN (2019) The effects of genomic germline variant reclassification on clinical cancer care. Oncotarget 10(4):417–423. https://doi.org/10.18632/oncotarget.26501
Soda T, Pereira S, Small BJ, Torgerson LN, Muñoz KA, Austin J, Lázaro-Muñoz G (2021) Child and adolescent psychiatrists’ perceptions of utility and self-rated knowledge of genetic testing predict usage for autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. https://doi.org/10.1016/j.jaac.2021.01.022
South ST, Lee C, Lamb AN, Higgins AW, Kearney HM, Working Group for the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee (2013) ACMG standards and guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: revision 2013. Genet Med off J Am Coll Med Genet 15(11):901–909. https://doi.org/10.1038/gim.2013.129
Srivastava S, Love-Nichols J, Dies KA, Ledbetter DH, Martin CL, Chung WK, The NDD Exome Scoping Review, Work Group (2019) Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med 21(11):2413–2421. https://doi.org/10.1038/s41436-019-0554-6
Srour M, Shevell M (2015) Global developmental delay and intellectual disability. In: Rosenberg’s molecular and genetic basis of neurological and psychiatric disease, 5th edn. Academic Press, p 151–161
Stravropoulos J, Shago M, Canadian microarray user group (2016) CCMG guidelines for genomic MIcroarray testing. CCMG, Laboratory Practice Committee. https://www.ccmg-ccgm.org/images/Guidelines/CCMG_Guidelines_for_Genomic_Microarray_Testing_FINAL.pdf
Sullivan PF, Owen MJ (2020) Increasing the clinical psychiatric knowledge base about pathogenic copy number variation. Ajp 177(3):204–209. https://doi.org/10.1176/appi.ajp.2019.19040335
Tammimies K, Marshall CR, Walker S, Kaur G, Thiruvahindrapuram B, Lionel AC, Fernandez BA (2015) Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disordermolecular diagnostic yield of genetic tests in children with autism molecular diagnostic yield of genetic tests in children with autism. JAMA 314(9):895–903. https://doi.org/10.1001/jama.2015.10078
Tansey KE, Rees E, Linden DE, Ripke S, Chambert KD, Moran JL, O’Donovan MC (2016) Common alleles contribute to schizophrenia in CNV carriers. Mol Psychiatry 21(8):1085–1089. https://doi.org/10.1038/mp.2015.143
Thurm A, Farmer C, Salzman E, Lord C, Bishop S (2019) State of the field: differentiating intellectual disability from autism spectrum disorder. Front Psychiatry 10:526. Retrieved from https://www.frontiersin.org/article/. https://doi.org/10.3389/fpsyt.2019.00526
Thygesen JH, Wolfe K, McQuillin A, Viñas-Jornet M, Baena N, Brison N, Vogels A (2018) Neurodevelopmental risk copy number variants in adults with intellectual disabilities and comorbid psychiatric disorders. Br J Psychiatry 212(5):287–294. https://doi.org/10.1192/bjp.2017.65
Turner SA, Rao SK, Morgan RH, Vnencak-Jones CL, Wiesner GL (2019) The impact of variant classification on the clinical management of hereditary cancer syndromes. Genet Med off J Am Coll Med Genet 21(2):426–430. https://doi.org/10.1038/s41436-018-0063-z
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Tibben A (2007) Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. Eur J Cancer (oxf Engl 1990) 43(1):71–77
Viñas-Jornet M, Esteba-Castillo S, Baena N, Ribas-Vidal N, Ruiz A, Torrents-Rodas D, Guitart M (2018) High incidence of copy number variants in adults with intellectual disability and co-morbid psychiatric disorders. Behav Genet 48(4):323–336. https://doi.org/10.1007/s10519-018-9902-6
Volkmar F, Siegel M, Woodbury-Smith M, King B, McCracken J, State M, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) (2014) Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry 53(2):237–257. https://doi.org/10.1016/j.jaac.2013.10.013
Voorwinden JS, Jaspers JP (2016) Prognostic factors for distress after genetic testing for hereditary cancer. J Genet Couns 25(3):495–503. https://doi.org/10.1007/s10897-015-9894-9
Vorstman JAS, Parr JR, Moreno-De-Luca D, Anney RJL, Nurnberger JI Jr, Hallmayer JF (2017) Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet 18(6):362–376. https://doi.org/10.1038/nrg.2017.4
Wassink TH, Piven J, Patil SR (2001) Chromosomal abnormalities in a clinic sample of individuals with autistic disorder. Psychiatr Genet 11(2):57–63
Webb BD, Scharf RJ, Spear EA, Edelmann LJ, Stroustrup A (2015) Evaluation of the affymetrix CytoScan(®) dx assay for developmental delay. Expert Rev Mol Diagn 15(2):185–192. https://doi.org/10.1586/14737159.2015.975213
Wey MC, Loh S, Doss JG, Abu Bakar AK, Kisely S (2016) The oral health of people with chronic schizophrenia: a neglected public health burden. Aust N Z J Psychiatry 50(7):685–694. https://doi.org/10.1177/0004867415615947
Willemsen MH, Vulto-van Silfhout AT, Nillesen WM, Wissink-Lindhout W, van Bokhoven H, Philip N, Kleefstra T (2011) Update on kleefstra syndrome. Mol Syndromol. https://doi.org/10.1159/000335648
Wilson JMG, Jungner G, World Health Organization (1968) Principles and practice of screening for disease. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/37650
Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C (2003) Prevalence of autism in a US metropolitan area. JAMA 289(1):49–55. https://doi.org/10.1001/jama.289.1.49
Zarrei M, Burton CL, Engchuan W, Young EJ, Higginbotham EJ, MacDonald JR, Scherer SW (2019) A large data resource of genomic copy number variation across neurodevelopmental disorders. NPJ Genom Med 4:26. https://doi.org/10.1038/s41525-019-0098-3
Acknowledgements
JA & EM are supported by BC Mental Health and Substance Use Services and thank the members of the Translational Psychiatric Genetics Group for their support. JA was supported by Canada Research Chairs Program.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflicts of interest.
Data availability
Not applicable.
Code availability
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Morris, E., O’Donovan, M., Virani, A. et al. An ethical analysis of divergent clinical approaches to the application of genetic testing for autism and schizophrenia. Hum Genet 141, 1069–1084 (2022). https://doi.org/10.1007/s00439-021-02349-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-021-02349-1